Twist Bioscience Corporation lost $2.08 per diluted share in fiscal year 2026. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 10 fiscal years, from 2017 to 2026, and the quarters Twist Bioscience Corporation has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Twist Bioscience Corporation lost $2.08 per diluted share in fiscal year 2026.
Twist Bioscience Corporation (TWST) reported a loss of $1.30 per diluted share in fiscal year 2025 and a loss of $2.08 per diluted share in fiscal year 2026. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 10 fiscal years this page covers, Twist Bioscience Corporation (TWST) diluted earnings per share went from -$24.49 in fiscal year 2017 to -$2.08 in fiscal year 2026.
Twist Bioscience Corporation (TWST) reported -$0.30 in diluted earnings per share in Q4 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Twist Bioscience Corporation (TWST) reported on that line in every period on record.